{
  "trial_id": "NCT04734756",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age \u2265 18 yrs.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Symptomatic moderate-to-severe (3+) or severe (4+) mitral valve regurgitation (DMR)",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "confirmed by transthoracic echocardiography.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "NYHA functional class II, III, IV.",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Left ventricular ejection fraction (LVEF) \u2265 20%.",
      "label": "met",
      "evidence": "EF of 65% on TTE"
    },
    {
      "criterion": "Anatomically suitable for transcatheter mitral valve repair by edge-to-edge technique,",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "and can be treated by the DragonflyTM device, as assessed by the site investigators",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "and confirmed by the echo core laboratory and eligibility committee.",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "High surgical risk as defined by either Society for Thoracic Surgery Risk Calculator score for valve replacement \u2265 8 points; or STS score for valve repair \u2265 6 points; or other high surgical risks.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Transseptal catheterization and femoral vein access is determined to be feasible.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "The subject or subject's legal representative has been informed of the nature of the trial, willing to accept the experimental tests, and has provided written informed consent.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Echocardiographic evidence of intra-cardiac mass, thrombus, or vegetation.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "The presence of other severe heart valve disease requiring surgical intervention.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Prior mitral valve leaflet surgery or transcatheter mitral valve intervention.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Estimated pulmonary artery systolic pressure (PASP) > 70 mm Hg assessed by echocardiography.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "History of acute myocardial infarction in the prior 4 weeks or untreated clinically significant coronary artery disease requiring revascularization.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery.",
  "_meta": {
    "topic_id": "12",
    "trial_id": "NCT04734756",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}